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Original Article Microscopic papillary thyroid cancer as an incidental Microscopic papillary thyroid cancer as an incidental Microscopic papillary thyroid cancer as an incidental Microscopic papillary thyroid cancer as an incidental Microscopic papillary thyroid cancer as an incidental finding in patients treated surgically for presumably finding in patients treated surgically for presumably finding in patients treated surgically for presumably finding in patients treated surgically for presumably finding in patients treated surgically for presumably benign thyroid disease benign thyroid disease benign thyroid disease benign thyroid disease benign thyroid disease P apillary thyroid microcarcinoma (PTMC) is defined as papillary thyroid cancer measuring less than 10 mm in its greatest diameter. [1] It represents the most common form of thyroid cancer and frequently remains clinically occult. A common clinical scenario is the incidental diagnosis of PTMC on histology of the resected thyroid following surgery for a presumably benign thyroid disease. Some controversy still persists regarding the optimal management of these patients. We present our experience in the management of patients with See editorial on page no. 5, 6
PTMC incidentally diagnosed following surgery for a presumably benign thyroid disease.
Materials and Methods
Histology reports of all 380 patients who underwent thyroidectomy during a 12-year period (Feb 1990 -Feb 2002 for a presumably benign disease were reviewed. All these patients were referred for surgery by the managing endocrinologist. The evaluation of these patients included a complete clinical examination, imaging of the thyroid (routine use of ultrasonography, selective use of thyroid scintigraphy and very exceptional use of computed tomography, mainly to determine the extent of substernal extension of a massively enlarged thyroid gland), and laboratory investigation (TSH, thyroxine and triiodothyronine levels, antithyroid peroxidase/ underwent lobectomy/isthmusectomy, while in another patient a total ipsilateral lobectomy/isthmusectomy and subtotal contralateral lobectomy was performed. In these three patients who underwent less than total or near-total thyroidectomy, a completion total thyroidectomy was performed at a second time when the final pathology analysis was completed. Mortality was zero and there was no significant morbidity, except transient hypocalcemia in four patients, probably as a result of ischemia of the parathyroid glands. Following surgery, adjuvant radioiodine therapy was given in 20 patients, at a dose of 80-100 mCi, usually four to six weeks following thyroid surgery. Patients were selected for radioiodine therapy based imaging evaluation. Preoperative diagnosis included mainly on the presence of multifocal PTMC and infiltration multinodular goiter, solitary nodule, Hashimoto's thyroiditis of the thyroid capsule and after an extensive discussion about and diffuse hyperplasia of the thyroid. Based on current the prognosis of PTMC and the advantages/disadvantages of therapeutic recommendations, we do not perform radioiodine adjuvant therapy. prophylactic cervical lymph node dissection, even in patients with preoperatively diagnosed thyroid cancer. Patients with
In our practice, following thyroid surgery most patients cytologically-proven (by using fine-needle aspiration cytology (including those with thyroid cancer) are seen every six months [FNAC]) preoperative diagnosis of thyroid malignancy were for two years postoperatively and then yearly. Follow-up visits excluded from this study. We identified patients with a include measurement of the serum thyroglobulin level, a chest postoperative, histologically proven diagnosis of PTMC as X-ray and a repeat
131
I scan after temporary (four to six weeks) an incidental finding unexpectedly diagnosed following deletion of hormonal replacement. Postoperative follow-up was thyroidectomy in patients with a presumably benign thyroid completed in 25 patients by regular examination, which disease. Histopathological examination of the resected included periodic clinical examination, thyroglobulin (Tg) specimen was performed as usual (i.e., with the serial measurements and neck ultrasonography (when indicated). sectioning technique, sections of 1 mm). Patient's Mean duration of follow-up is 4.56 years (range, 1-12 years). demographics, pathology findings, management and All these patients were alive and disease-free at the time of the outcomes are discussed.
completion of the follow-up.
Results Discussion
A series of 27 patients (7.1% of the total number of patients, PTMC is a common type of papillary thyroid cancer. In this 19 females and eight males) with incidental PTMC is study, PTMC was diagnosed in 7.1% of patients with presented. These patients were treated surgically for presumably benign thyroid disease. It may be possible that this presumably benign thyroid disease (multinodular goiter = 20 is an underestimate of the true incidence, because we have patients, follicular adenoma = 6 patients, diffuse hyperplasia not used the serial sectioning technique. In autopsy studies, of the thyroid = 1 patient). Chronic lymphocytic thyroiditis the incidence of PTMC ranges from 3-36%. [2, 3] Because of this (Hashimoto) was also present in four of the patients with high incidence, Harach et al. from Finland concluded that multinodular thyroiditis. Mean age at the time of surgery was "…occult papillary thyroid carcinoma are so common in 45.2 years (38.37 for males and 48 for females). Based on the Finland … that they can be regarded as a normal finding".
[3]
results of preoperative evaluation (mainly ultrasonography) and Similarly, in surgical studies, incidental foci of PTMC were intraoperative findings, cervical lymphadenopathy was not found in a large percentage of patients after thyroidectomy for found in any of the 27 patients of this study.
Mean diameter of PTMC was 4.4 mm (range, 1-10 mm). In 11 patients (40.7%) the tumor was multifocal (two tumor foci in seven patients, three tumor foci in three patients and four tumor foci in one patient). Multifocal tumors were located at the same lobe in five patients, while in the other six patients the tumor foci were found in both thyroid lobes. In two patients (7.4%), the thyroid capsule was infiltrated by the tumor, probably as a result of the peripheral location of the PTMC within the thyroid parenchyma.
Total or near-total (leaving no more than 3 g of thyroid tissue) thyroidectomy was the most commonly performed surgical procedure. In 24 patients, total/near-total thyroidectomy was performed at the time of initial surgery. Two patients a presumably benign thyroid disease, ranging from 2-24%. In our study, PTMC was diagnosed in 7.1% (27 of 380) of patients who were treated surgically for presumably benign thyroid disease. Multifocality is common in PTMC and is observed in 20-46% of cases (~ 41% in this study). Interestingly, lymph node metastases (usually micrometastases) can be detected in a significant percentage of patients with PTMC (up to 40%) and, in a small percentage of patients, these metastases may precede the clinical evidence of the primary tumor. [7] The high incidence of PTMC in autopsy studies suggests that most of them have a relatively "benign" biological behavior. These studies showed that a significant percentage of patients (up to 36%) who died of diseases other than thyroid cancer had PTMC that remained asymptomatic throughout their lives. [3, 8] The discordance between the prevalence of PTMC and population estimates of death from cancer further support that PTMC is an indolent disease. [9, 10] The diagnosis of PTMC is usually based on a combination of clinical examination, laboratory investigations and specialized radiological techniques. However, PTMC is often clinically undetectable because of its small size and usually remains clinically silent, discovered as an incidental finding at autopsy or in specimens of thyroid removed for other reasons. However, with the advent of improved methods of diagnostic evaluation (usually neck ultrasonography and image-guided FNAC), the limited thyroid resection (i.e., lobectomy/isthmusectomy or subtotal thyroidectomy) for presumably benign thyroid disease should be completion (total or near-total) thyroidectomy.
[2, 16] Others, however, have suggested that completion thyroidectomy is not indicated in selected patients with incidental PTMC, such as patients with well-differentiated tumor and with no enlarged lymph nodes. [17] Due to the high prevalence of incidental PTMC we also favor total/near-total thyroidectomy as the procedure of choice during the initial surgery for all nodular thyroid disease (multinodular goiter or dominant, presumably benign nodules).
[18] This avoids the need for reoperation for patients with incidental PTMC. This seems diagnosis can now often be made preoperatively. Nowadays, particularly reasonable because other groups have previously tumors between 1 and 2 mm in diameter can be detected with reported a risk for benign contralateral nodule growth requiring the use of high-resolution transducers. [11] It was the recognition reoperation after lobectomy for nodular goiter. [19, 20] Surely, this of this fact that has led Salvadori et al. to question the term is the clinical experience of many endocrine surgeons. Routine "occult", frequently used in the past to describe PTMC. [12] use of thyroxine to suppress TSH secretion is recommended Most authors recommend ultrasound-guided FNAC for thyroid in the management of PTMC.
[21]
nodules larger than 10 mm. [13] neck lymph node dissection is indicated in the presence of cervical lymphadenopathy and is preferred over the "berry A limitation of the present study is the lack of a control group picking procedure". [22, 23] Adjuvant radioiodine therapy is treated by a less aggressive therapeutic protocol. However, the indicated at least in selected patients with PTMC, based on aim of this study is not to compare different treatments in the the presence of adverse prognostic factors, such as tumor management of incidental PTMC in patients with presumably multicentricity, positive lymph nodes, capsular or vascular benign thyroid disease, but to emphasize the problem that invasion; prognostic scoring systems (such as the AMES) may both the clinician and the patient face in this clinical scenario. be used to select patients for radioiodine therapy. The findings of this study could serve as an additional factor in favor of a more radical and aggressive therapeutic References management in patients with presumably benign nodular thyroid disease. Despite continuing controversy, in our clinical of transformation of the in-thyroid-recurrence from welldifferentiated to undifferentiated. [14, 15] Performing total/near total thyroidectomy at the time of the initial surgery avoids the risk of reoperation which is associated with an increased morbidity; obviously, the avoidance of a second procedure is preferable for both the patient and the surgeon. Additional advantages of total/near-total thyroidectomy are the possibility of better monitoring of treated patients by scintigraphic scan and thyroglobulin measurements to detect residual or recurrent disease and the increase of the yield of postoperative radioactive iodine therapy.
[2,13] Interestingly, hormone replacement therapy will be required in most patients (> 50%) following more limited thyroid resections (i.e., lobectomy plus isthmusectomy and/or subtotal thyroidectomy), thereby eliminating the theoretical advantage of less radical thyroid surgery. The management of PTMC incidentally diagnosed following a ) .
